Abstract Background Glioblastoma Multiforme (GBM) is the most common and lethal form of
primary brain tumor in adults. Following standard treatment of surgery, radiation and …

Background New drugs are constantly sought after to improve the survival of patients with
malignant gliomas. The ideal substance would selectively target tumor cells without eliciting …

Glioblastoma multiforme (GBM) is the most common primary malignant brain tumor. Despite
standard multimodality treatment, the highly aggressive nature of GBM makes it one of the …

Gliomas are common and aggressive brain tumors that carry a poor prognosis. The current
multimodal therapeutic option for glioma includes surgery subsequently temozolomide …

Curcumin is a polyphenolic compound derived from the Indian spice turmeric. We used
nanoparticle-encapsulated curcumin to treat medulloblastoma and glioblastoma cells. This …

Glioblastoma (GBM) is the most malignant brain tumor and accounts for most adult brain
tumors. Current available treatment options for GBM are multimodal, which include surgical …

Previous studies suggested that curcumin is a potential agent against glioblastomas
(GBMs). However, the in vivo efficacy of curcumin in gliomas remains not established. In this …

The treatment of glioblastoma is challenging for the clinician, due to its chemotherapeutic
resistance. Recent findings suggest that targeting glioblastoma using anti-cancer natural …

Glioblastoma (GBM) is a highly aggressive brain tumor characterized by increased
proliferation and resistance to chemotherapy and radiotherapy. Recently, a growing body of …

Brain malignancies currently carry a poor prognosis despite the current multimodal standard
of care that includes surgical resection and adjuvant chemotherapy and radiation. As new …